Worldwide Under-Funding of Stroke Research

The clinical and financial burdens of stroke are considerable. Stroke is the leading cause of death and disability in the developed world and incidence is rapidly increasing in the developing world. However, investment in research to combat stroke has been remarkably poor. Studies from the United Kingdom, Europe and the United States have shown a highly consistent picture, with considerably lower levels of funding for stroke research compared with cancer and heart disease. Without better funding for stroke research, it is unlikely that progress in prevention and treatment will offset the projected increases in the burden of stroke. Stroke physicians and public interest groups need to be active advocates in securing increased funding for stroke research.

[1]  N. Powe,et al.  The relation between funding by the National Institutes of Health and the burden of disease. , 1999, The New England journal of medicine.

[2]  J. Olesen,et al.  The burden of brain diseases in Europe , 2003, European journal of neurology.

[3]  P. Rothwell,et al.  A Systematic Comparison of the Quality and Volume of Published Data Available on Novel Risk Factors for Stroke versus Coronary Heart Disease , 2005, Cerebrovascular Diseases.

[4]  J F Toole,et al.  The global burden of disease study: implications for neurology. , 2000, Archives of neurology.

[5]  P. Rothwell,et al.  The high cost of not funding stroke research: a comparison with heart disease and cancer , 2001, The Lancet.

[6]  J. Toole,et al.  Federal Funding for Research in Stroke and Trauma - A Clinical Investigator's Viewpoint , 1984, Stroke.

[7]  C. Wolfe,et al.  The impact of stroke. , 2000, British medical bulletin.

[8]  G. Moneta,et al.  Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study) , 2007 .

[9]  Josemir W Sander,et al.  The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. , 2000, Brain : a journal of neurology.

[10]  J. A. Costa e Silva,et al.  The World Health Organization's global initiative on neurology and public health. , 1997, Journal of the neurological sciences.

[11]  Michael Chopp,et al.  The temporal evolution of MRI tissue signatures after transient middle cerebral artery occlusion in rat , 1997, Journal of the Neurological Sciences.

[12]  Louette R. Johnson Lutjens.  Research , 2006 .

[13]  Anna Czlonkowska,et al.  Underfunding of Stroke Research: A Europe-Wide Problem , 2004, Stroke.

[14]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[15]  J. Broderick.  Gross underfunding of stroke research , 2004, The Lancet Neurology.

[16]  K. Asplund,et al.  Exploring the declining case fatality in acute stroke. Population‐based observations in the northern Sweden MONICA Project , 1996, Journal of internal medicine.

[17]  Ruth Bonita,et al.  Epidemiology of stroke , 1992, The Lancet.

[18]  Wade S. Smith,et al.  Effect of a US National Institutes of Health programme of clinical trials on public health and costs , 2006, The Lancet.